Shares of Health Care sector company AbbVie moved -1.0% today, and are now trading at a price of $170.39. The Large-Cap stock's daily volume was 12,308,051 compared to its average volume of 5,292,501. The S&P 500 index returned a -0.0% performance.
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals worldwide. The company is based in North Chicago and has 50,000 full time employees. Its market capitalization is $300,886,589,440. AbbVie currently offers its equity investors a dividend that yields 3.5% per year.
25 analysts are following AbbVie and have set target prices ranging from $170.0 to $207.0 per share. On average, they have given the company a rating of buy. At today's prices, ABBV is trading -7.44% away from its average analyst target price of $184.08 per share.
Over the last year, ABBV's share price has increased by 26.3%, which represents a difference of 0.0% when compared to the S&P 500. The stock's 52 week high is $182.89 per share whereas its 52 week low is $130.96. With average free cash flows of $18.44 Billion that have been growing at an average rate of 11.5% over the last 5 years, AbbVie is in a position to continue its strong stock performance trend.
| Date Reported | Cash Flow from Operations ($ k) | Capital expenditures ($ k) | Free Cash Flow ($ k) | YoY Growth (%) |
|---|---|---|---|---|
| 2023 | 22,839,000 | 777,000 | 22,062,000 | -9.02 |
| 2022 | 24,943,000 | 695,000 | 24,248,000 | 10.27 |
| 2021 | 22,777,000 | 787,000 | 21,990,000 | 30.97 |
| 2020 | 17,588,000 | 798,000 | 16,790,000 | 31.46 |
| 2019 | 13,324,000 | 552,000 | 12,772,000 | -0.13 |
| 2018 | 13,427,000 | 638,000 | 12,789,000 |
